Carcinogenesis Advance Access originally published online on February 12, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 25, No. 7, 1243-1247,
July 2004
Carcinogenesis vol.25 no.7 © Oxford University Press 2004; all rights reserved.
ARTICLE |
Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC
AT transition mutations in a population exposed to methylating agents
1 Department of Gastrointestinal Surgery, Wythenshawe Hospital, Southmoor Road, Wythenshawe, Manchester M23 9LT, 2 Cancer Research UK Carcinogenesis Group, Paterson Institute for Cancer Research, Christie Hospital, Manchester M20 4BX and 3 School of Epidemiology and Health Sciences, Medical School, The University of Manchester, Oxford Road, Manchester M13 9PT, UK
4 To whom correspondence should be addressed Email: a.povey{at}man.ac.uk
There is increasing evidence to suggest that O6-alkyl guanine DNA-alkyltransferase (MGMT) activity provides protection against alkylating agent induced formation of GC
AT transition mutations in the K-ras oncogene of colorectal tumours. As this mutagenic event occurs during the growth of adenomas, both biomarkers of exposure (N7-methylguanine levels in DNA) and susceptibility (MGMT activity) were measured in biopsy samples obtained from normal and adenomatous tissue from 34 patients with large adenomas (>10 mm in size). There was no correlation between MGMT activity in the adenoma and in matched normal tissue. However, MGMT activity was significantly lower in adenoma tissue than in adjacent normal mucosa (5.18 versus 7.05 fmol/µg DNA, P = 0.01), particularly in men and those whose age was greater than the median. Upon stratification by K-ras mutational status, MGMT activity was lower in adenomas bearing a K-ras GCAT transition mutation (mean 4.21 fmol/µg DNA) than in adjacent normal tissue (mean 7.7 fmol/µg DNA; P < 0.004). In contrast, there was no significant difference in MGMT activity in adenomas lacking a K-ras GCAT transition mutation and adjacent normal mucosa. N7-methylguanine levels however did not vary with age, gender, K-ras mutational status or MGMT activity. These results are consistent with the acquisition of K-ras GCAT transition mutations in adenomas with low MGMT activity as a result of unavoidable exposure to methylating agents.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N P Lees, K L Harrison, C N Hall, G P Margison, and A C Povey Human colorectal mucosal O6-alkylguanine DNA-alkyltransferase activity and DNA-N7-methylguanine levels in colorectal adenoma cases and matched referents Gut, March 1, 2007; 56(3): 380 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Niture, C. S. Velu, Q. R. Smith, G.J. Bhat, and K. S. Srivenugopal Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines Carcinogenesis, February 1, 2007; 28(2): 378 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Frigola, X. Sole, M. F. Paz, V. Moreno, M. Esteller, G. Capella, and M. A. Peinado Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer Hum. Mol. Genet., January 15, 2005; 14(2): 319 - 326. [Abstract] [Full Text] [PDF]
|
|